Literature DB >> 6349998

A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides.

M Orlowski, C Michaud, T G Chu.   

Abstract

A metalloendopeptidase, optimally active at a neutral pH, was purified from the soluble fraction of brain homogenates. The enzyme (molecular weight about 67000) is strongly inhibited by metal chelators such as EDTA and o-phenanthroline. An EDTA-treated enzyme can be reactivated by several divalent metal ions including Zn2+, Co2+ and Mn2+. The specificity and kinetic parameters of the enzyme were studied with a series of model synthetic substrates. The enzyme preferentially cleaves peptide bonds in which the carbonyl group is contributed by an aromatic amino acid residue in the P1 position. The lowest Km values and the highest Kcat/Km ratios were obtained with substrates having aromatic residues in the P'3 and P1 position or in the P'3 and both the P1 and P2 positions. Lower kcat/Km ratios were obtained with substrates having arginine residues in position P1, and even lower values with those substrates having a glycine or aspartyl residue in this position. Introduction of a D-amino acid residue in either position P1 or P'1 renders the substrate totally resistant to hydrolysis. The specificity studies suggest that the active site of the metalloendopeptidase can accommodate at least five amino acid residues, with two of those residues binding on the N-terminal side and three binding on the C-terminal side of the hydrolyzed bond. Several biologically active peptides are cleaved by the enzyme at sites consistent with the specificity deduced from studies with model synthetic substrates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349998     DOI: 10.1111/j.1432-1033.1983.tb07620.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  42 in total

1.  Structural and functional studies of the metalloendopeptidase (EC 3.4.24.15) involved in degrading gonadotropin releasing hormone.

Authors:  M J Glucksman; M Orlowski; J L Roberts
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

2.  Purification and characterization of a soluble endopeptidase from rat bone.

Authors:  A M Bollen; K K Makinen
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

Review 3.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

4.  Intracellular peptides as natural regulators of cell signaling.

Authors:  Fernanda M Cunha; Denise A Berti; Zulma S Ferreira; Clécio F Klitzke; Regina P Markus; Emer S Ferro
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

5.  Distinction between endo-oligopeptidase A (EC 3.4.22.19) and soluble metalloendopeptidase (EC 3.4.24.15)

Authors:  A C Camargo
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

6.  Thimet oligopeptidase (EC 3.4.24.15): the same by any name?

Authors:  A J Barrett
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

7.  Metabolism of amyloid precursor protein in COS cells transfected with a beta-secretase candidate.

Authors:  H Koike; Z Kouchi; T Kinouchi; T Maeda; H Sorimachi; T C Saido; K Maruyama; A Okuyama; K Suzuki; S Ishiura
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

8.  Purification, kinetic and functional characterization of membrane bound dipeptidyl peptidase-III from NCDC 252: a probiotic lactic acid bacteria.

Authors:  Pooja Attri; Drukshakshi Jodha; Jasbir Singh; Suman Dhanda
Journal:  Mol Biol Rep       Date:  2018-07-23       Impact factor: 2.316

9.  Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.

Authors:  E A DelBel; A P Padovan; G J Padovan; O Z Sellinger; A R Martins
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

10.  Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.

Authors:  R A Lew; F Tomoda; R G Evans; L Lakat; J H Boublik; L A Pipolo; A I Smith
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.